Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-Year Outcomes in "Real-World" Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS]).
Kandzari DE, Amjadi N, Caputo C, Rowe SK, Williams J, Tamboli HP, Christen T, Allocco DJ, Dawkins KD. Kandzari DE, et al. Among authors: christen t. Am J Cardiol. 2016 Feb 15;117(4):539-545. doi: 10.1016/j.amjcard.2015.11.043. Epub 2015 Dec 7. Am J Cardiol. 2016. PMID: 26732420 Free article.
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
Meredith IT, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco DJ. Meredith IT, et al. Among authors: christen t. EuroIntervention. 2018 Apr 20;13(17):2047-2050. doi: 10.4244/EIJ-D-17-00529. EuroIntervention. 2018. PMID: 28923786 Free article. Clinical Trial.
Clinical outcomes in unselected patients treated with the PROMUS Element platinum-chromium, everolimus-eluting stent: Final five-year results from the PE PROVE Study.
Moreno R, Legrand V, Ferrario M, MacCarthy P, Redwood S, Werner N, Jung W, Ungi I, Zaman A, Richardt G, Crowley J, Schwimmbeck P, Christen T, Allocco DJ, Meredith IT. Moreno R, et al. Among authors: christen t. Catheter Cardiovasc Interv. 2019 Feb 15;93(3):398-403. doi: 10.1002/ccd.27835. Epub 2018 Oct 20. Catheter Cardiovasc Interv. 2019. PMID: 30341836
Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention.
Mauri L, Kirtane AJ, Windecker S, Yeh RW, Dauerman HL, Price MJ, Christen T, Allocco DJ, Meredith IT, Kereiakes DJ. Mauri L, et al. Among authors: christen t. Am Heart J. 2018 Nov;205:110-117. doi: 10.1016/j.ahj.2018.08.004. Epub 2018 Aug 17. Am Heart J. 2018. PMID: 30218844 Clinical Trial.
Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.
Kereiakes DJ, Meredith IT, Windecker S, Lee Jobe R, Mehta SR, Sarembock IJ, Feldman RL, Stein B, Dubois C, Grady T, Saito S, Kimura T, Christen T, Allocco DJ, Dawkins KD. Kereiakes DJ, et al. Among authors: christen t. Circ Cardiovasc Interv. 2015 Apr;8(4):e002372. doi: 10.1161/CIRCINTERVENTIONS.114.002372. Circ Cardiovasc Interv. 2015. PMID: 25855680 Free article. Clinical Trial.
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement".
Garratt KN, Weaver WD, Jenkins RG, Pow TK, Mauri L, Kereiakes DJ, Winters KJ, Christen T, Allocco DJ, Lee DP. Garratt KN, et al. Among authors: christen t. Circulation. 2015 Sep 29;132(13):e166-7. doi: 10.1161/CIRCULATIONAHA.115.016779. Circulation. 2015. PMID: 26416639 No abstract available.
126 results